Mengyi Lao

79 Qingchun Rd
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma.

Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma.

Journal: Science advances
Published: May 21, 2025

Risk Factors, Manifestations, and Implications of Chyle Leak following Pancreatic Surgery: The Volume May Outweigh the Milky Appearance of the Drainage in a Chyle Leak.

Risk Factors, Manifestations, and Implications of Chyle Leak following Pancreatic Surgery: The Volume May Outweigh the Milky Appearance of the Drainage in a Chyle Leak.

Journal: Annals of surgery
Published: December 11, 2024

Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer.

Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer.

Journal: Nature communications
Published: November 26, 2024

Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.

Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.

Journal: The Journal of clinical investigation
Published: September 12, 2024

Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy.

Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy.

Journal: Cancer communications (London, England)
Published: June 10, 2024

Optimizing the Management Strategies of Delayed Postpancreaticoduodenectomy Hemorrhage: Lessons From 2013 Consecutive Pancreaticoduodenectomies.

Optimizing the Management Strategies of Delayed Postpancreaticoduodenectomy Hemorrhage: Lessons From 2013 Consecutive Pancreaticoduodenectomies.

Journal: Annals of surgery
Published: April 22, 2024

The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.

The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.

Journal: BMC cancer
Published: January 30, 2024

Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance.

Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance.

Journal: Autophagy
Published: January 04, 2024

Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy.

Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 26, 2023

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial.

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial.

Journal: BMC cancer
Published: March 26, 2022

RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Journal: Molecular medicine (Cambridge, Mass.)
Published: February 21, 2022

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer.

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer.

Journal: Cell death and differentiation
Published: January 29, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026